OMERS ADMINISTRATION Corp Purchases 3,735 Shares of CME Group Inc. $CME

OMERS ADMINISTRATION Corp increased its holdings in CME Group Inc. (NASDAQ:CME) by 24.9% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 18,756 shares of the financial services provider’s stock after acquiring an additional 3,735 shares during the quarter. OMERS ADMINISTRATION Corp’s holdings in CME Group were worth $5,540,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in the stock. 44 Wealth Management LLC bought a new stake in CME Group in the first quarter worth $272,000. Lombard Odier Asset Management Switzerland SA purchased a new position in shares of CME Group in the 1st quarter worth about $1,385,000. Waverly Advisors LLC boosted its stake in CME Group by 1.5% in the 1st quarter. Waverly Advisors LLC now owns 49,039 shares of the financial services provider’s stock worth $14,484,000 after purchasing an additional 728 shares in the last quarter. Wealth Alliance LLC boosted its stake in CME Group by 30.9% in the 1st quarter. Wealth Alliance LLC now owns 6,886 shares of the financial services provider’s stock worth $2,034,000 after purchasing an additional 1,627 shares in the last quarter. Finally, Epoch Investment Partners Inc. grew its position in CME Group by 6.7% during the 1st quarter. Epoch Investment Partners Inc. now owns 60,370 shares of the financial services provider’s stock valued at $17,830,000 after purchasing an additional 3,765 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors.

CME Group News Summary

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME Group’s Q2 results topped expectations, and the stock was reported higher on the earnings beat. US Stock Market: CME shares jump 6% after Q2 profit beats estimates; strong hedging demand boosts results
• Positive Sentiment: Analysts noted strong fundamentals and at least one rating upgrade following the earnings release, which can support investor confidence. CME Group: Q2 Earnings Results Lead To A Rating Upgrade
• Neutral Sentiment: UBS reiterated a Hold rating and kept its $260 target, signaling solid fundamentals but limited upside at current valuation. Neutral Stance Reiterated on CME as Solid Fundamentals Meet Valuation Limits; $260 Price Target Maintained
• Negative Sentiment: Bank of America and JPMorgan both maintained bearish/underweight views, even though they slightly raised price targets, highlighting ongoing caution about upside. Analyst price target updates
• Negative Sentiment: Short-interest data showed no meaningful short position, so this headline is unlikely to be a real stock driver and does not change the core thesis.

Insiders Place Their Bets

In other news, Director William R. Shepard purchased 325 shares of the company’s stock in a transaction dated Thursday, June 25th. The shares were purchased at an average cost of $230.57 per share, for a total transaction of $74,935.25. Following the purchase, the director directly owned 260,442 shares in the company, valued at approximately $60,050,111.94. This represents a 0.12% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, insider Hilda Harris Piell sold 5,753 shares of CME Group stock in a transaction on Monday, May 18th. The stock was sold at an average price of $304.63, for a total value of $1,752,536.39. Following the completion of the sale, the insider directly owned 27,702 shares of the company’s stock, valued at $8,438,860.26. The trade was a 17.20% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.30% of the stock is currently owned by insiders.

CME Group Price Performance

CME opened at $255.31 on Monday. The company’s 50-day simple moving average is $254.13 and its two-hundred day simple moving average is $281.27. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The stock has a market capitalization of $92.51 billion, a P/E ratio of 21.65, a P/E/G ratio of 2.98 and a beta of 0.25. CME Group Inc. has a 52-week low of $218.31 and a 52-week high of $329.16.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 EPS for the quarter, topping analysts’ consensus estimates of $2.91 by $0.08. CME Group had a net margin of 63.30% and a return on equity of 15.60%. The firm had revenue of $1.71 billion during the quarter, compared to analyst estimates of $1.68 billion. During the same period in the previous year, the business posted $2.96 earnings per share. The business’s revenue for the quarter was up .8% on a year-over-year basis. As a group, analysts predict that CME Group Inc. will post 12.27 EPS for the current year.

CME Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, June 25th. Shareholders of record on Tuesday, June 9th were given a $1.30 dividend. This represents a $5.20 dividend on an annualized basis and a yield of 2.0%. The ex-dividend date of this dividend was Tuesday, June 9th. CME Group’s payout ratio is 44.11%.

Analysts Set New Price Targets

A number of analysts have weighed in on CME shares. JPMorgan Chase & Co. raised their price objective on shares of CME Group from $249.00 to $250.00 and gave the company an “underweight” rating in a research note on Thursday. The Goldman Sachs Group cut their price target on shares of CME Group from $267.00 to $245.00 and set a “sell” rating on the stock in a report on Tuesday, June 30th. Bank of America raised their price target on shares of CME Group from $226.00 to $230.00 and gave the company an “underperform” rating in a research report on Thursday. Jefferies Financial Group decreased their price objective on shares of CME Group from $356.00 to $349.00 and set a “buy” rating for the company in a report on Thursday, April 9th. Finally, Piper Sandler lowered their price objective on CME Group from $329.00 to $295.00 and set an “overweight” rating on the stock in a research report on Wednesday, July 15th. Eleven research analysts have rated the stock with a Buy rating, four have issued a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $291.81.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.